Search Language English 日本語 Our People Global Presence Open submenu (Regions) Regions Open submenu (Offices) Offices Open submenu (Client liaison) Client liaison Expertise Open submenu (Services) Services Open submenu (Sectors) Sectors Open submenu (About Us) About Us Open submenu (Insights) Insights Contact Us Life Sciences Specialists Working with us Insights Leading life sciences IP experts Technical and legal capabilities accurately matched to your needs Intellectual property is a critical asset in the life sciences sector. With Marks & Clerk, you work with leading life science experts, whose technical and legal capabilities are accurately matched to your needs. People who understand your world and are experienced in identifying, protecting, enforcing and maximising the value of IP rights for life sciences businesses. Technical and sector expertise Marks & Clerk has a large team of leading life science experts. The size of our team means that we have extensive expertise in all life science technical areas, including small molecules, biologics, molecular biology, gene therapy, virology, plant biotechnology, vaccines, wounds, immunology, bioinformatics and diagnostic methods. We also have expertise in all other exclusivities particular to the life sciences sector, including: supplementary protection certificates (SPCs) for medicinal and plant protection products patent term extensions regulatory exclusivities plant variety rights. Specialists for the result you need Monique Chu Partner Chinese and Chartered (UK) Patent Attorney Monique has notable experience in biotechnology, pharmaceutical, cosmetic related and mechanical inventions. James Baker Partner Canadian Patent Agent James Baker is a partner and registered Canadian patent agent in the Ottawa office of Marks & Clerk Canada. Upasana Patel Partner Registered (SG) and Chartered (UK) Patent Attorney Upasana qualified as a Singapore Registered Patent Attorney in 2007 and as a Chartered (UK) Patent Attorney in 2012. Will Nieuwenhuys Partner Chartered (UK) and European Patent Attorney Will has experience in a variety of technical fields, with particular expertise in small molecule organic and pharmaceutical chemistry. Integrated team We work collaboratively across different disciplines to achieve the best possible outcome Our team includes patent attorneys, trade mark attorneys, commercial lawyers and IP litigators. This combined expertise and experience means that we can provide every type of intellectual property service you need from the moment an invention is identified through to enforcement or defence of IP rights in opposition proceedings or litigation. We’re used to working collaboratively across different disciplines to achieve the best possible outcomes for our clients. As well as identifying, enforcing and defending IP rights, we carry out life science due diligence projects and commercial work, including when preparing for investment and IPOs. Our team acts in high value disputes before the courts and patent offices, often in coordinated, multi-jurisdictional proceedings. Clients Our life sciences team acts for world-leading multinationals as well as start-ups, universities, public sector organisations, and established SMEs. Our clients include businesses from the pharmaceutical, biotechnology, food technology and agritech sectors. “The group stands out for its particularly busy Patent Cooperation Treaty (PCT) patent filing practice and its longstanding experience in matters at the intersection of litigation and prosecution, making the team a popular choice for sophisticated matters, especially for pharmaceutical and biopharmaceutical companies.” The Legal 500, 2020 “Pharmaceutical multinationals flock to the firm with cross-jurisdictional litigation and transactions instructions, alongside routine filing and prosecution tasks” IAM Patent 1000, 2020 Latest Insights Insight - 03 November 2021 M&C Reacts: Neurim v Mylan: A Most Unusual Case - Take Two Part Two In a further preliminary skirmish in the Neurim v Mylan battle, the Patents Court has granted Neurim’s wish to have its day in court. Mylan (now Viatris) failed in its bid to stay the UK proceedings pending determination of the EPO opposition proceedings. Read more Insight - 15 October 2021 Royalty Pharma v Boehringer: The UK’s Patents Court takes on the German law of licence negotiations and EPC 2000 purpose-limited product claims This article discusses the Royalty Pharma v Boehringer judgment from the UK’s Patents Court which covers a number of interesting points on German patent licensing and substantive patent law. Read more Insight - 05 October 2021 Patentability of known substances in Europe Even if a substance is known, there are plenty of possible routes that could be explored in order to obtain patent protection. Read more Stay informed IP insights direct to your inbox Subscribe Terms & Conditions Privacy Notice Cookies Legal Notices Lexology Mondaq